Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Parkinson's Disease | Research

Carpets with visual cues can improve gait in Parkinson’s disease patients: may be independent of executive function

Authors: Ze-Di Hu, Shi-Guo Zhu, Jie-Fan Huang, Jin-Yu Chen, Shi-Shi Huang, Rong-Pei Liu, Zhu-Ling Chen, Lu-Lu Ma, Xiong Zhang, Jian-Yong Wang

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

Gait impairment is common in Parkinson’s disease (PD) patients, which greatly reduces their quality of life. Executive dysfunction is associated with gait impairment. Compensatory strategies, including visual cues, have been shown to be effective in improving PD gait. In this study, we aimed to understand whether carpets with visual cues could improve PD gait, and how the improvement varies across patients with different executive function state.

Methods

We designed carpets with chessboard and stripe cues. A total of 65 Chinese PD patients were recruited. Movement Disorder Society Unified Parkinson’s Disease Rating Scale, L-dopa equivalent daily dosage, Hoehn & Yahr stage, Frontal Assessment Battery, Mini Mental State Examination Scale, Hamilton Anxiety Scale, and Hamilton Depression Scale were evaluated. Gait parameters including stride length, gait speed and fall risk were recorded by a wearable electronic device.

Results

The stride length and gait speed were significantly improved and the fall risk was significantly mitigated when PD patients walked on carpets with chessboard and stripe patterns. Further analysis showed the amelioration of gait parameters was independent of executive dysfunction.

Conclusions

Our study demonstrates that carpets with visual cues can improve the gait of PD patients even in those with mild executive dysfunction.
Literature
1.
go back to reference Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, et al. Prevalence of Alzheimer’s disease and Parkinson’s disease in China: an updated systematical analysis. Front Aging Neurosci. 2020;12: 603854.PubMedPubMedCentralCrossRef Cui L, Hou NN, Wu HM, Zuo X, Lian YZ, Zhang CN, et al. Prevalence of Alzheimer’s disease and Parkinson’s disease in China: an updated systematical analysis. Front Aging Neurosci. 2020;12: 603854.PubMedPubMedCentralCrossRef
3.
go back to reference Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18:697–708.PubMedCrossRef Mirelman A, Bonato P, Camicioli R, Ellis TD, Giladi N, Hamilton JL, et al. Gait impairments in Parkinson’s disease. Lancet Neurol. 2019;18:697–708.PubMedCrossRef
4.
go back to reference Palmerini L, Rocchi L, Mazilu S, Gazit E, Hausdorff JM, Chiari L. Identification of characteristic motor patterns preceding freezing of gait in Parkinson’s disease using wearable sensors. Front Neurol. 2017;8:394.PubMedPubMedCentralCrossRef Palmerini L, Rocchi L, Mazilu S, Gazit E, Hausdorff JM, Chiari L. Identification of characteristic motor patterns preceding freezing of gait in Parkinson’s disease using wearable sensors. Front Neurol. 2017;8:394.PubMedPubMedCentralCrossRef
5.
go back to reference Shah J, Pillai L, Williams DK, Doerhoff SM, Larson-Prior L, Garcia-Rill E, et al. Increased foot strike variability in Parkinson’s disease patients with freezing of gait. Parkinsonism Relat Disord. 2018;53:58–63.PubMedPubMedCentralCrossRef Shah J, Pillai L, Williams DK, Doerhoff SM, Larson-Prior L, Garcia-Rill E, et al. Increased foot strike variability in Parkinson’s disease patients with freezing of gait. Parkinsonism Relat Disord. 2018;53:58–63.PubMedPubMedCentralCrossRef
6.
go back to reference Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson’s disease. J Neurol Sci. 2006;248:173–6.PubMedCrossRef Giladi N, Hausdorff JM. The role of mental function in the pathogenesis of freezing of gait in Parkinson’s disease. J Neurol Sci. 2006;248:173–6.PubMedCrossRef
7.
go back to reference Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23:329–42 (quiz 472).PubMedCrossRef Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008;23:329–42 (quiz 472).PubMedCrossRef
8.
go back to reference Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.PubMedCrossRef Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23:2129–70.PubMedCrossRef
9.
go back to reference Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord. 2000;6:165–70.PubMedCrossRef Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord. 2000;6:165–70.PubMedCrossRef
10.
go back to reference Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.PubMedCrossRef Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39:142–8.PubMedCrossRef
11.
go back to reference Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919–23.PubMedPubMedCentral Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, et al. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J. 1985;132:919–23.PubMedPubMedCentral
12.
go back to reference Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, et al. Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: critique and recommendations. Mov Disord. 2016;31:1342–55.PubMedCrossRef Bloem BR, Marinus J, Almeida Q, Dibble L, Nieuwboer A, Post B, et al. Measurement instruments to assess posture, gait, and balance in Parkinson’s disease: critique and recommendations. Mov Disord. 2016;31:1342–55.PubMedCrossRef
13.
go back to reference Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord. 2015;30:1361–70.PubMedPubMedCentralCrossRef Curtze C, Nutt JG, Carlson-Kuhta P, Mancini M, Horak FB. Levodopa is a double-edged sword for balance and gait in people with Parkinson’s disease. Mov Disord. 2015;30:1361–70.PubMedPubMedCentralCrossRef
14.
go back to reference Sterling NW, Cusumano JP, Shaham N, Piazza SJ, Liu G, Kong L, et al. Dopaminergic modulation of arm swing during gait among Parkinson’s disease patients. J Parkinsons Dis. 2015;5:141–50.PubMedPubMedCentralCrossRef Sterling NW, Cusumano JP, Shaham N, Piazza SJ, Liu G, Kong L, et al. Dopaminergic modulation of arm swing during gait among Parkinson’s disease patients. J Parkinsons Dis. 2015;5:141–50.PubMedPubMedCentralCrossRef
15.
go back to reference Okuma Y, Silva de Lima AL, Fukae J, Bloem BR, Snijders AH. A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson’s disease. Parkinsonism Relat Disord. 2018;46:30–5.PubMedCrossRef Okuma Y, Silva de Lima AL, Fukae J, Bloem BR, Snijders AH. A prospective study of falls in relation to freezing of gait and response fluctuations in Parkinson’s disease. Parkinsonism Relat Disord. 2018;46:30–5.PubMedCrossRef
16.
go back to reference Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems AM, Kwakkel G, et al. The effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of people with Parkinson’s disease. Arch Phys Med Rehabil. 2005;86:999–1006.PubMedCrossRef Rochester L, Hetherington V, Jones D, Nieuwboer A, Willems AM, Kwakkel G, et al. The effect of external rhythmic cues (auditory and visual) on walking during a functional task in homes of people with Parkinson’s disease. Arch Phys Med Rehabil. 2005;86:999–1006.PubMedCrossRef
17.
go back to reference Barthel C, Nonnekes J, van Helvert M, Haan R, Janssen A, Delval A, et al. The laser shoes: a new ambulatory device to alleviate freezing of gait in Parkinson disease. Neurology. 2018;90:e164–71.PubMedCrossRef Barthel C, Nonnekes J, van Helvert M, Haan R, Janssen A, Delval A, et al. The laser shoes: a new ambulatory device to alleviate freezing of gait in Parkinson disease. Neurology. 2018;90:e164–71.PubMedCrossRef
18.
go back to reference Warlop T, Detrembleur C, Buxes Lopez M, Stoquart G, Lejeune T, Jeanjean A. Does Nordic walking restore the temporal organization of gait variability in Parkinson’s disease? J Neuroeng Rehabil. 2017;14:17.PubMedPubMedCentralCrossRef Warlop T, Detrembleur C, Buxes Lopez M, Stoquart G, Lejeune T, Jeanjean A. Does Nordic walking restore the temporal organization of gait variability in Parkinson’s disease? J Neuroeng Rehabil. 2017;14:17.PubMedPubMedCentralCrossRef
19.
go back to reference Rutz DG, Benninger DH. Physical therapy for freezing of gait and gait impairments in Parkinson disease: a systematic review. PM R. 2020;12:1140–56.PubMedCrossRef Rutz DG, Benninger DH. Physical therapy for freezing of gait and gait impairments in Parkinson disease: a systematic review. PM R. 2020;12:1140–56.PubMedCrossRef
20.
go back to reference Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, et al. Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. BMJ. 2012;345: e5004.PubMedPubMedCentralCrossRef Tomlinson CL, Patel S, Meek C, Herd CP, Clarke CE, Stowe R, et al. Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis. BMJ. 2012;345: e5004.PubMedPubMedCentralCrossRef
21.
go back to reference Gal O, Polakova K, Hoskovcova M, Tomandl J, Capek V, Berka R, et al. Pavement patterns can be designed to improve gait in Parkinson’s disease patients. Mov Disord. 2019;34:1831–8.PubMedCrossRef Gal O, Polakova K, Hoskovcova M, Tomandl J, Capek V, Berka R, et al. Pavement patterns can be designed to improve gait in Parkinson’s disease patients. Mov Disord. 2019;34:1831–8.PubMedCrossRef
22.
go back to reference Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.PubMedCrossRef Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30:1591–601.PubMedCrossRef
23.
go back to reference Bordelon YM, Hays RD, Vassar SD, Diaz N, Bronstein J, Vickrey BG. Medication responsiveness of motor symptoms in a population-based study of Parkinson disease. Parkinsons Dis. 2011;2011: 967839.PubMedPubMedCentral Bordelon YM, Hays RD, Vassar SD, Diaz N, Bronstein J, Vickrey BG. Medication responsiveness of motor symptoms in a population-based study of Parkinson disease. Parkinsons Dis. 2011;2011: 967839.PubMedPubMedCentral
24.
go back to reference Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–6.PubMedCrossRef Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology. 2000;55:1621–6.PubMedCrossRef
25.
go back to reference Pelicioni PHS, Menant JC, Henderson EJ, Latt MD, Brodie MA, Lord SR. Mild and marked executive dysfunction and falls in people with Parkinson’s disease. Braz J Phys Ther. 2021;25:437–43.PubMedCrossRef Pelicioni PHS, Menant JC, Henderson EJ, Latt MD, Brodie MA, Lord SR. Mild and marked executive dysfunction and falls in people with Parkinson’s disease. Braz J Phys Ther. 2021;25:437–43.PubMedCrossRef
26.
go back to reference Zhu S, Zhong M, Bai Y, Wu Z, Gu R, Jiang X, et al. The Association between clinical characteristics and motor symptom laterality in patients with Parkinson’s disease. Front Neurol. 2021;12: 663232.PubMedPubMedCentralCrossRef Zhu S, Zhong M, Bai Y, Wu Z, Gu R, Jiang X, et al. The Association between clinical characteristics and motor symptom laterality in patients with Parkinson’s disease. Front Neurol. 2021;12: 663232.PubMedPubMedCentralCrossRef
27.
go back to reference Wu Z, Jiang X, Zhong M, Shen B, Zhu J, Pan Y, et al. Wearable sensors measure ankle joint changes of patients with Parkinson’s disease before and after acute levodopa challenge. Parkinsons Dis. 2020;2020:2976535.PubMedPubMedCentral Wu Z, Jiang X, Zhong M, Shen B, Zhu J, Pan Y, et al. Wearable sensors measure ankle joint changes of patients with Parkinson’s disease before and after acute levodopa challenge. Parkinsons Dis. 2020;2020:2976535.PubMedPubMedCentral
28.
go back to reference Taylor ME, Delbaere K, Mikolaizak AS, Lord SR, Close JC. Gait parameter risk factors for falls under simple and dual task conditions in cognitively impaired older people. Gait Posture. 2013;37:126–30.PubMedCrossRef Taylor ME, Delbaere K, Mikolaizak AS, Lord SR, Close JC. Gait parameter risk factors for falls under simple and dual task conditions in cognitively impaired older people. Gait Posture. 2013;37:126–30.PubMedCrossRef
29.
go back to reference Cheng Q, Wu M, Wu Y, Hu Y, Kwapong WR, Shi X, et al. Weaker braking force, a new marker of worse gait stability in Alzheimer disease. Front Aging Neurosci. 2020;12: 554168.PubMedPubMedCentralCrossRef Cheng Q, Wu M, Wu Y, Hu Y, Kwapong WR, Shi X, et al. Weaker braking force, a new marker of worse gait stability in Alzheimer disease. Front Aging Neurosci. 2020;12: 554168.PubMedPubMedCentralCrossRef
30.
go back to reference Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72:721–5.PubMedPubMedCentralCrossRef Wood BH, Bilclough JA, Bowron A, Walker RW. Incidence and prediction of falls in Parkinson’s disease: a prospective multidisciplinary study. J Neurol Neurosurg Psychiatry. 2002;72:721–5.PubMedPubMedCentralCrossRef
31.
go back to reference Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis. 2013;2013: 906274.PubMedPubMedCentral Allen NE, Schwarzel AK, Canning CG. Recurrent falls in Parkinson’s disease: a systematic review. Parkinsons Dis. 2013;2013: 906274.PubMedPubMedCentral
32.
go back to reference Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L. Falls in Parkinson’s disease: a complex and evolving picture. Mov Disord. 2017;32:1524–36.PubMedCrossRef Fasano A, Canning CG, Hausdorff JM, Lord S, Rochester L. Falls in Parkinson’s disease: a complex and evolving picture. Mov Disord. 2017;32:1524–36.PubMedCrossRef
33.
go back to reference Serrao M, Ranavolo A, Conte C, Davassi C, Mari S, Fasano A, et al. Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study. J Neurol. 2015;262:2539–47.PubMedCrossRef Serrao M, Ranavolo A, Conte C, Davassi C, Mari S, Fasano A, et al. Effect of 24-h continuous rotigotine treatment on stationary and non-stationary locomotion in de novo patients with Parkinson disease in an open-label uncontrolled study. J Neurol. 2015;262:2539–47.PubMedCrossRef
34.
go back to reference Jankovic J, Berkovich E, Eyal E, Tolosa E. Symptomatic efficacy of rasagiline monotherapy in early Parkinson’s disease: post-hoc analyses from the ADAGIO trial. Parkinsonism Relat Disord. 2014;20:640–3.PubMedCrossRef Jankovic J, Berkovich E, Eyal E, Tolosa E. Symptomatic efficacy of rasagiline monotherapy in early Parkinson’s disease: post-hoc analyses from the ADAGIO trial. Parkinsonism Relat Disord. 2014;20:640–3.PubMedCrossRef
35.
go back to reference Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, et al. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:249–58.PubMedCrossRef Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JC, et al. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:249–58.PubMedCrossRef
36.
go back to reference Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75:1263–9.PubMedPubMedCentralCrossRef Chung KA, Lobb BM, Nutt JG, Horak FB. Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology. 2010;75:1263–9.PubMedPubMedCentralCrossRef
37.
go back to reference Nonnekes J, Ruzicka E, Nieuwboer A, Hallett M, Fasano A, Bloem BR. Compensation strategies for gait impairments in Parkinson disease: a review. JAMA Neurol. 2019;76:718–25.PubMedCrossRef Nonnekes J, Ruzicka E, Nieuwboer A, Hallett M, Fasano A, Bloem BR. Compensation strategies for gait impairments in Parkinson disease: a review. JAMA Neurol. 2019;76:718–25.PubMedCrossRef
38.
go back to reference Tosserams A, Weerdesteyn V, Bal T, Bloem BR, Solis-Escalante T, Nonnekes J. Cortical correlates of gait compensation strategies in Parkinson disease. Ann Neurol. 2022;91:329–41.PubMedPubMedCentralCrossRef Tosserams A, Weerdesteyn V, Bal T, Bloem BR, Solis-Escalante T, Nonnekes J. Cortical correlates of gait compensation strategies in Parkinson disease. Ann Neurol. 2022;91:329–41.PubMedPubMedCentralCrossRef
39.
go back to reference Maidan I, Bernad-Elazari H, Gazit E, Giladi N, Hausdorff JM, Mirelman A. Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures. J Neurol. 2015;262:899–908.PubMedCrossRef Maidan I, Bernad-Elazari H, Gazit E, Giladi N, Hausdorff JM, Mirelman A. Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures. J Neurol. 2015;262:899–908.PubMedCrossRef
40.
go back to reference Arie L, Herman T, Shema-Shiratzky S, Giladi N, Hausdorff JM. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson’s disease motor subtypes? Findings from a 5-year prospective study. J Neurol. 2017;264:2149–57.PubMedCrossRef Arie L, Herman T, Shema-Shiratzky S, Giladi N, Hausdorff JM. Do cognition and other non-motor symptoms decline similarly among patients with Parkinson’s disease motor subtypes? Findings from a 5-year prospective study. J Neurol. 2017;264:2149–57.PubMedCrossRef
41.
go back to reference Gilat M, Ehgoetz Martens KA, Miranda-Dominguez O, Arpan I, Shine JM, Mancini M, et al. Dysfunctional limbic circuitry underlying freezing of gait in Parkinson’s disease. Neuroscience. 2018;374:119–32.PubMedCrossRef Gilat M, Ehgoetz Martens KA, Miranda-Dominguez O, Arpan I, Shine JM, Mancini M, et al. Dysfunctional limbic circuitry underlying freezing of gait in Parkinson’s disease. Neuroscience. 2018;374:119–32.PubMedCrossRef
Metadata
Title
Carpets with visual cues can improve gait in Parkinson’s disease patients: may be independent of executive function
Authors
Ze-Di Hu
Shi-Guo Zhu
Jie-Fan Huang
Jin-Yu Chen
Shi-Shi Huang
Rong-Pei Liu
Zhu-Ling Chen
Lu-Lu Ma
Xiong Zhang
Jian-Yong Wang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01472-1

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue